Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Seven-Gene Signature Aggregates a Subgroup of Stage II Colon Cancers with Stage III

1 Oct 2012

Abstract excerpt

Colorectal cancer is one of the most common cancers in the world. Histological staging is efficient, but combination with molecular markers may improve tumor classification. Gene expression profiles have been defined as prognosis predictors among stage II and III tumors, but their implementation in medical practice remains controversial. Stage II tumors have been recognized as a heterogeneous group, and high-risk...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to Colorectal Cancer Treatments and Studies
Share to Genetic factors in colorectal cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 22917480
DOI: 10.1089/omi.2012.0039

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Seven-Gene Signature Aggregates a Subgroup of Stage II Colon Cancers with Stage IIIPMID 22917480Read ↗

Hypoxia-Driven Gene Expression Is an Independent Prognostic Factor in Stage II and III Colon Cancer PatientsSemantic proximity Read ↗

Gene expression classification of colon cancer into molecular subtypes: characterization, validation, and prognostic value.Semantic proximity Read ↗

Subgroups and prognostication in stage III colon cancer: future perspectives for adjuvant therapy.Semantic proximity Read ↗

Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer.Semantic proximity Read ↗

A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sourcesSemantic proximity Read ↗

Interconnectivity between molecular subtypes and tumor stage in colorectal cancerSemantic proximity Read ↗

Stage II Colon Cancer Prognosis Prediction by Tumor Gene Expression ProfilingSemantic proximity Read ↗

Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysisSemantic proximity Read ↗

Genomic Profiling of Stage II Colorectal Cancer Identifies Candidate Genes Associated with Recurrence-Free Survival, Tumor Location, and Differentiation Grade.Semantic proximity Read ↗

CDX2 as a Prognostic Biomarker in Stage II and Stage III Colon CancerSemantic proximity Read ↗

A DNA methylation signature for the prediction of tumour recurrence in stage II colorectal cancerSemantic proximity Read ↗

Molecular subtyping improves prognostication of Stage 2 colorectal cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.